Web Desk
The Indian Council of Medical Research (ICMR) has partnered with Bharat Biotech International Limited (BBIL) to fast track clinical trials of the indigenous COVID-19 vaccine. ICMR’s National Institute of Virology (NIV) in Pune has provided the virus strain to BBIL to develop the vaccine.
The clinical trials will be held in 12 institutes across the country. In a letter to these institutes, the ICMR stated that it aims to launch the vaccine for public health use by August 15, after completion of all clinical trials.
Meanwhile, India’s second COVID-19 vaccine produced pharma giant Zydus Cadila got approval from the Drug Controller General of India (DCGI) to conduct phase I and phase II human clinical trials.
By Joseph Maliakan You scratch an Indian, the caste comes out , irrespective of whether…
SRUTHI MATHAA… LAYA PITHAA… The International Chamber for Indian Music & Culture, an international initiative…
By Joseph Maliakan The Viksit Bharat Shiksha Adhishthan ( VBSA) ,Bill 2025 to replace the…
Kochi: A prominent NRI who is known for his corporate finance expertise and association with…
By Joseph Maliakan As a reporter who has witnessed the continuous erosion of academic freedoms…
KOCHI: The significance of the Comprehensive Economic Partnership Agreement (CEPA) as a catalyst to boost…
This website uses cookies.